Wednesday, February 10, 2010, 10:01AM AEST - The Australian Stockmarket closes in 6 hours and 4 minutes.
To create a watchlist or portfolio of shares, Register

Quidel Corp. (QDEL)

 8:00AM AEST: 12.63 USD  Down 0.35 (2.70%)  
 MORE ON QDEL 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Quidel Corporation (NasdaqNM:QDEL) Delayed quote dataEdit
Last Trade:12.63 USD
Trade Time: 8:00AM AEST
Change:Down 0.35 (2.70%)
Prev Close:12.98
Open:13.10
Bid:12.29 x 100
Ask:13.80 x 100
1y Target Est:18.67
Day's Range:12.57 - 13.25
52wk Range:7.05 - 18.81
Volume:356,801
Avg Vol (3m):356,532
Market Cap:380.74M
P/E (ttm):20.77
EPS (ttm):0.61
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add QDEL to Portfolio   Download Data

 HEADLINES 
•Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010
Business Wire (Sat, Jan 30)
•3 Healthy Small Caps
at Investopedia (Fri, Jan 29)
•Scott Brown Health Care Buys
at Forbes.com (Tue, Jan 26)
•An In-Depth Look At Diagnostics Companies And Stock Evaluations From Dr. Ashim Anand Of Natixis Bleichroeder, LLC
Wall Street Transcript (Tue, Jan 26)
•QUIDEL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 23)
•[$$] Two Picks Among Life-Science Suppliers
at Barrons.com (Fri, Jan 15)
•Ohio University Proves 26 Years Is Worth The Wait
at The Wall Street Journal Online (Wed, Jan 13)
•Quidel buying Diagnostic Hybrids for $130 million
AP (Tue, Jan 12)
•QUIDEL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Mon, Jan 11)
•Deals of the day -- mergers and acquisitions
at Reuters (Mon, Jan 11)
•UPDATE - Quidel to buy Diagnostic Hybrids for $130 mln
at Reuters (Mon, Jan 11)
More Headlines for QDEL...
 ANALYST 
EPS Est (next year) (Dec-09) :0.90
EPS Est (in 2 years) (Dec-10) :0.66
Avg Rec (current)*:1.6
PEG Ratio:0.85
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Quidel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of point-of-care (POC) diagnostic solutions for infectious diseases, and reproductive and women's health.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices